Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-08-01

FDA Approved: AZURETTE — Original Application (Mayne Pharma Inc.)

View source ↗

Summary

FDA approved Mayne Pharma's Azurette, an oral contraceptive containing desogestrel and ethinyl estradiol under an original ANDA submission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZURETTE (Desogestrel/ethinyl estradiol and ethinyl estradiol)

Snippet

ORIG AP for AZURETTE (DESOGESTREL/ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL)